Switch to Lisdexamfetamine in the Treatment of Attention-Deficit Disorder at a Psychiatric Outpatient Clinic for School-Aged Children: A Danish Cohort Study-Reference-Cited by-同舟云学术

Switch to Lisdexamfetamine in the Treatment of Attention-Deficit Disorder at a Psychiatric Outpatient Clinic for School-Aged Children: A Danish Cohort Study

Published:2024-04-01 Issue:3 Volume:34 Page:137-147
ISSN:1044-5463
Container-title:Journal of Child and Adolescent Psychopharmacology
language:en
Short-container-title:Journal of Child and Adolescent Psychopharmacology

Author:

Søndergaard Nanna Roed¹^ORCID,Nørøxe Karen Busk¹,Carlsen Anders Helles¹,Randing Stine Helene¹,Warrer Pernille²,Thomsen Per Hove¹³,Clausen Loa¹³

Affiliation:

1. Department of Child and Adolescent Psychiatry, Aarhus University Hospital, Psychiatry, Aarhus, Denmark.

2. Department of Patient Safety, Zealand Pharma, Søborg, Denmark.

3. Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/cap.2023.0077

Reference44 articles.

1. Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: A Phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study

2. Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology

3. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials

4. Attention-Deficit/Hyperactivity Disorder with Inadequate Response to Stimulants: Approaches to Management

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From the Editor-in-Chief’s Desk: Advancing Evidence-Based Treatments for Disruptive Mood Dysregulation Disorder;Journal of Child and Adolescent Psychopharmacology;2024-06-01

2. From the Editor-in-Chief's Desk: Advances in Patient-Centered Treatment for Attention-Deficit/Hyperactivity Disorder;Journal of Child and Adolescent Psychopharmacology;2024-04-01